{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:31:55Z","timestamp":1761741115595,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":154,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2020]]},"DOI":"10.6061\/clinics\/2020\/e1529","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T14:11:41Z","timestamp":1591798301000},"page":"e1529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and laboratory parameters as predictors of long-term outcome according to the etiology of underlying chronic liver disease in patients who underwent liver transplantation for hepatocellular carcinoma treatment"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-5593","authenticated-orcid":false,"given":"Paulo Henrique Costa","family":"Diniz","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-0323","authenticated-orcid":false,"given":"Serena Dafne do Carmo","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-3491","authenticated-orcid":false,"given":"Luciana Costa","family":"Faria","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7003-5159","authenticated-orcid":false,"given":"Paula Vieira Teixeira","family":"Vidigal","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-2294","authenticated-orcid":false,"given":"Teresa Cristina de Abreu","family":"Ferrari","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"12","key":"10.6061\/clinics\/2020\/e1529_bib1","article-title":"The Burden of Primary Liver Cancer and Underlying Etiologies from 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2020\/e1529_bib2","first-page":"S1","article-title":"Enhancing clinical outcomes in hepatocellular carcinoma","volume":"33","author":"Abou-Alfa","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.6061\/clinics\/2020\/e1529_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cgh.2011.03.027","article-title":"Factors that affect risk for hepatocellular carcinoma and effects of surveillance","volume":"9","author":"Yang","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1529_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1529_bib5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1053\/j.gastro.2008.02.013","article-title":"Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival","volume":"134","author":"Ioannou","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1665-2681(19)30845-2","article-title":"Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort","volume":"13","author":"Paranagu\u00e1-Vezozzo","year":"2014","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1590\/0102-6720201600040007","article-title":"Liver transplantation for carcinoma hepatocellular in S\u00e3o Paulo: 414 cases by the Milan\/Brazil Criteria","volume":"29","author":"S\u00e1","year":"2016","journal-title":"Arq Bras Cir Dig"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1529_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1529_bib9","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/lt.21078","article-title":"Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence","volume":"13","author":"Partiff","year":"2007","journal-title":"Liver Transpl"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1529_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10620-011-1910-9","article-title":"Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era","volume":"57","author":"Sharma","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.6061\/clinics\/2020\/e1529_bib12","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1038\/cddis.2011.136","article-title":"BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy","volume":"3","author":"Colombino","year":"2012","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1529_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.22709","article-title":"Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia","volume":"49","author":"International Consensus Group for Hepatocellular Neoplasia","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1529_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"8","key":"10.6061\/clinics\/2020\/e1529_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1529_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00009947","article-title":"Pattern and management of recurrent hepatocellular carcinoma after liver transplantation","volume":"5","author":"Regalia","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/lt.20128","article-title":"Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis","volume":"10","author":"Roayaie","year":"2004","journal-title":"Liver Transpl"},{"issue":"12","key":"10.6061\/clinics\/2020\/e1529_bib18","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/lt.20303","article-title":"Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C","volume":"10","author":"Shimoda","year":"2004","journal-title":"Liver Transpl"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1529_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00000658-200105000-00009","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"233","author":"Hemming","year":"2001","journal-title":"Ann Surg"},{"issue":"11","key":"10.6061\/clinics\/2020\/e1529_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/lt.20311","article-title":"Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study","volume":"10","author":"Leung","year":"2004","journal-title":"Liver Transpl"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1529_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00268-001-0214-1","article-title":"Liver transplantation for malignant diseases: selection and pattern of recurrence","volume":"26","author":"Margarit","year":"2002","journal-title":"World J Surg"},{"issue":"12","key":"10.6061\/clinics\/2020\/e1529_bib22","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2005.00289.x","article-title":"Predictors of long-term survival after liver transplantation for hepatocellular carcinoma","volume":"100","author":"Zavaglia","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"23","key":"10.6061\/clinics\/2020\/e1529_bib23","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1200\/JCO.2003.11.137","article-title":"The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time","volume":"21","author":"Yoo","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.6061\/clinics\/2020\/e1529_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/jlts.2002.34922","article-title":"Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations","volume":"8","author":"Libbrecht","year":"2002","journal-title":"Liver Transpl"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.TP.0000152801.82734.74","article-title":"Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic?","volume":"79","author":"Sotiropoulos","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"10.6061\/clinics\/2020\/e1529_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/lt.24117","article-title":"Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation","volume":"21","author":"Chaiteerakij","year":"2015","journal-title":"Liver Transpl"},{"key":"10.6061\/clinics\/2020\/e1529_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","article-title":"Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J Carcinog"},{"issue":"6","key":"10.6061\/clinics\/2020\/e1529_bib28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1200\/JCO.2016.69.5197","article-title":"Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials","volume":"35","author":"Jackson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1529_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2014.7189","article-title":"Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial","volume":"312","author":"Zhu","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.6061\/clinics\/2020\/e1529_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729240","article-title":"The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer","volume":"24","author":"Shiani","year":"2017","journal-title":"Cancer Control"},{"issue":"7","key":"10.6061\/clinics\/2020\/e1529_bib32","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/carcin\/bgn113","article-title":"Recent advances in the natural history of hepatocellular carcinoma","volume":"29","author":"Trevisani","year":"2008","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1529_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.1840160122","article-title":"Natural history of small untreated hepatocelular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival","volume":"16","author":"Barbara","year":"1992","journal-title":"Hepatology"},{"issue":"2","key":"10.6061\/clinics\/2020\/e1529_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jhep.2005.03.014","article-title":"Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis","volume":"43","author":"Cucchetti","year":"2005","journal-title":"J Hepatol"},{"issue":"9","key":"10.6061\/clinics\/2020\/e1529_bib35","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1097-0142(19950501)75:9<2220::AID-CNCR2820750906>3.0.CO;2-4","article-title":"Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients","volume":"75","author":"Trevisani","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"10.6061\/clinics\/2020\/e1529_bib36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ijc.2910450411","article-title":"The capsule surrounding primary liver tumors: wherefrom its prognostic significance?","volume":"45","author":"Grigioni","year":"1990","journal-title":"Int J Cancer"},{"issue":"1","key":"10.6061\/clinics\/2020\/e1529_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/0037-8682-0176-2015","article-title":"Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century","volume":"49","author":"Souto","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"10.6061\/clinics\/2020\/e1529_bib38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J Hepatol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:54:29Z","timestamp":1761720869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222003040"},"secondary":[{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322020000100237&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7247738\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/clinical-and-laboratory-parameters-as-predictors-of-long-term-outcome-according-to-the-etiology-of-underlying-chronic-liver-disease-in-patients-who-underwent-liver-transplantation-for-hepatocellular-c\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":38,"alternative-id":["S1807593222003040"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1529","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and laboratory parameters as predictors of long-term outcome according to the etiology of underlying chronic liver disease in patients who underwent liver transplantation for hepatocellular carcinoma treatment","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2020\/e1529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e1529"}}